Search

everythinglearnresearchcommunity

for

Search:↓

Kidney transplant patients who had COVID-19 experienced a significant drop in their quality of life due to long-lasting symptoms.

Pharmacist-led care significantly improved post-COVID symptoms.

Most severe COVID-19 patients in Mexico experienced long-lasting symptoms that worsened their quality of life.

The COVID-19 pandemic led to an increase in untreated hair diseases and showed the importance of teledermatology.

Severe COVID-19 may cause hair loss, and doctors recommend supplements and topical treatments to manage it.

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.

COVID-19-related hair loss may have unique features compared to hair loss from other causes.

Many COVID-19 survivors experience long-term symptoms like fatigue and sleep issues, needing ongoing medical support.

After severe COVID-19, lung damage can improve, detected effectively by lung-ultrasound, and high pressure support during hospitalization can increase lung artery size. Also, about 22% of patients had lung blood clots, and when treated, they recovered faster.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

COVID-19 infection and vaccination may trigger hair loss and rapid hair whitening.

Some people experienced hair loss after COVID-19 vaccination, but it's very rare and vaccines' benefits are greater than this risk.

Most skin issues were due to COVID-19, with some caused by vaccines or treatments, and were categorized into five types.

Some people with a history of autoimmune hair loss experienced worsening symptoms after COVID-19 vaccination.

Different methods, including stress management, healthy diet, supplements, and treatments like minoxidil, can help hair grow back after COVID-19 related hair loss.

COVID-19 infection may cause hair loss.

COVID-19 can cause skin issues like chilblains and rashes, which may help in early detection, especially in patients without other symptoms.

Men are more likely to have severe COVID-19 cases and fatalities than women due to factors like lifestyle, aging, and biological differences.

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.

COVID-19 can cause skin issues like hives, rashes, and chickenpox-like eruptions, with women aged 31-40 being the most affected.

Androgens may worsen COVID-19 and hair loss could indicate the disease's severity.

The COVID-19 pandemic led to fewer dermatology patients, more stress-related skin conditions during the crisis, and a rise in contact dermatitis after, with ongoing concerns for public health and treatment delays.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

COVID-19 may trigger or worsen rapid hair loss in alopecia areata.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Baricitinib helps improve hair growth in severe alopecia, with better results in less severe cases and higher doses working faster.

Resident doctors had more facial skin discoloration than medical students during COVID-19.

Monocytes might be linked to hair loss after COVID-19.

Nearly half of the studied men with long COVID had low testosterone, including younger men.